Department of Intensive Care Unit, Peking University Third Hospital, Beijing, China.
Department of Genetics, Stanford University School of Medicine, Stanford, California.
Shock. 2021 Jan 1;55(1):128-137. doi: 10.1097/SHK.0000000000001593.
Intra-abdominal hypertension (IAH), the leading complication in the intensive care unit, significantly disturbs the gut microbial composition by decreasing the relative abundance of Lactobacillus and increasing the relative abundance of opportunistic infectious bacteria.
To evaluate the preventative effect of Lactobacillus-based probiotics on IAH-induced intestinal barrier damages, a single-species probiotics (L92) and a multispecies probiotics (VSL#3) were introduced orally to Sprague-Dawley rats for 7 days before inducing IAH. The intestinal histology and permeability to macromolecules (fluoresceine isothiocyanate, FITC-dextran, N = 8 for each group), the parameters of immunomodulatory and oxidative responses [monocyte chemotactic protein 1 (MCP-1), interleukin-1β (IL-1β), interleukin-4 (IL-4), interleukin-10 (IL-10), malonaldehyde, glutathione peroxidase (GSH- Px), catalase (CAT), and superoxide dismutase; N = 4 for each group], and the microbiome profiling (N = 4 for each group) were analyzed.
Seven-day pretreatments of L92 significantly alleviated the IAH-induced increase in intestinal permeability to FITC-dextran and histological damage (P < 0.0001), accompanied with the suppression of inflammatory and oxidative activation. The increase of MCP-1 and IL-1β was significantly inhibited (P < 0.05); the anti-inflammatory cytokines, IL-4, and IL-10 were maintained at high levels; and the suppression of CAT (P < 0.05) was significantly reversed when pretreated with L92. On the contrary, no significant protective effects were observed in the VSL#3-pretreated group. Among the 84 identified species, 260 MetaCyc pathways, and 217 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, the protective effects of L92 were correlated with an increased relative abundance of Bacteroides finegoldii, Odoribacter splanchnicus, and the global activation of amino acid biosynthesis pathways, especially the glutamate-glutamine biosynthesis pathway.
Seven-day pretreatment with a single-species probiotics can prevent IAH-induced severe intestinal barrier dysfunction, potentially through microbial modulation.
腹腔内高压(IAH)是重症监护病房的主要并发症,它通过降低乳酸杆菌的相对丰度和增加机会性感染细菌的相对丰度,显著改变肠道微生物组成。
为了评估基于乳杆菌的益生菌对 IAH 诱导的肠道屏障损伤的预防作用,将单种益生菌(L92)和多种益生菌(VSL#3)分别口服给 Sprague-Dawley 大鼠 7 天,然后诱导 IAH。分析肠道组织学和大分子通透性(荧光素异硫氰酸酯,FITC-葡聚糖,每组 8 只)、免疫调节和氧化反应参数[单核细胞趋化蛋白 1(MCP-1)、白细胞介素 1β(IL-1β)、白细胞介素 4(IL-4)、白细胞介素 10(IL-10)、丙二醛、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)和超氧化物歧化酶;每组 4 只]以及微生物组特征(每组 4 只)。
L92 的 7 天预处理显著减轻了 IAH 诱导的 FITC-葡聚糖和组织学损伤引起的肠道通透性增加(P < 0.0001),同时抑制了炎症和氧化激活。MCP-1 和 IL-1β 的增加明显受到抑制(P < 0.05);抗炎细胞因子 IL-4 和 IL-10 维持在较高水平;并且当用 L92 预处理时,CAT 的抑制作用(P < 0.05)明显逆转。相反,在 VSL#3 预处理组中未观察到明显的保护作用。在 84 种鉴定的物种、260 个 MetaCyc 途径和 217 个京都基因与基因组百科全书(KEGG)途径中,L92 的保护作用与相对丰度增加的双歧杆菌、奥氏杆菌和氨基酸生物合成途径的全局激活相关,特别是谷氨酸-谷氨酰胺生物合成途径。
7 天的单种益生菌预处理可以预防 IAH 引起的严重肠道屏障功能障碍,可能通过微生物调节。